E. Rudolph Froesch

E. Rudolph Froesch's AcademicInfluence.com Rankings

E. Rudolph Froesch

Philosophy

#6642

World Rank

#9708

Historical Rank

Logic

#3777

World Rank

#4985

Historical Rank

philosophy Degrees

E. Rudolph Froesch

Biology

#8994

World Rank

#12146

Historical Rank

Endocrinology

#103

World Rank

#114

Historical Rank

Molecular Biology

#1183

World Rank

#1209

Historical Rank

Biochemistry

#1339

World Rank

#1460

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

E. Rudolph Froesch's Degrees

PhD Biochemistry University of California, San Francisco
Doctorate Medicine Stanford University

Why Is E. Rudolph Froesch Influential?

(Suggest an Edit or Addition)

(See a Problem?)

E. Rudolph Froesch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Actions of insulin-like growth factors. (1985) (1116)
Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. (1981) (604)
Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. (1987) (578)
Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. (1989) (512)
Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. (1983) (453)
ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY. (1963) (413)
Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. (1978) (337)
Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. (1989) (315)
Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. (1986) (312)
Insulin-like growth factors. Studies in diabetics with and without retinopathy. (1983) (305)
Biological and immunological properties of insulin-like growth factors (IGF) I and II. (1984) (262)
Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. (1975) (238)
Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. (1986) (237)
Hereditary fructose intolerance. An inborn defect of hepatic fructose-1-phosphate splitting aldolase. (1963) (234)
Insulin-like growth factors in the fed and fasted states. (1982) (223)
Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. (1989) (220)
Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. (1978) (219)
The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. (1981) (184)
Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. (1993) (176)
Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. (1985) (172)
Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? (1992) (172)
Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. (1979) (169)
Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man. (1989) (163)
Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. (1990) (152)
Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor. (1981) (144)
Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. (1988) (136)
Disorders of fructose metabolism (1976) (135)
Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? (1991) (128)
Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth. (1986) (128)
Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. (1998) (127)
Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. (1994) (125)
Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. (1983) (124)
Non-suppressible insulin-like activity of human serum. I. Physicochemical properties, extraction and partial purification. (1966) (123)
Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. (1994) (123)
Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. (1983) (120)
Dwarfism in the pygmy. An isolated deficiency of insulin-like growth factor I. (1981) (118)
Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia. (1990) (114)
The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. (1975) (113)
Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. (1994) (111)
Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. (1989) (108)
Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. (1990) (108)
Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage. (1976) (101)
Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity. (1966) (99)
Insulin and non-suppressible insulin-like activity (NSILA-s): evidence for separate plasma membrane receptor sites. (1974) (93)
FATE OF RAT INSULIN IN RAT-LIVER PERFUSION STUDIED BY ADIPOSE-TISSUE ASSAY. (1963) (92)
Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. (1977) (89)
BROMOCRIPTINE: DOES IT JEOPARDISE THE RESULT OF LATER SURGERY FOR PROLACTINOMAS? (1982) (86)
Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA. (1968) (84)
Insulin-like growth factors and insulin: comparative aspects (1985) (80)
Insulin-like growth factor I in the dog: a study in different dog breeds and in dogs with growth hormone elevation. (1984) (80)
Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors. (1988) (72)
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. (1993) (70)
Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? (1982) (67)
Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. (1995) (64)
Specific binding of nonsupressible insulinlike activity to chicken embryo fibroblasts and to a solubilized fibroblast receptor. (1975) (61)
Determination of nonsuppressible insulin-like activity in human serum by a sensitive protein-binding assay. (1977) (61)
Studies on the site of action of the arylsulfonylureas in man. (1956) (60)
Familial Cushing's syndrome with primary adrenocortical microadenomatosis (primary adrenocortical nodular dysplasia). (1980) (54)
Growth-hormone dependence of non-suppressible insulin-like activity (NSILA) and of NSILA-carrier protein in rats. (1978) (51)
Nonsuppressible insulinlike activity of human serum: purification, physiochemical and biological properties and its relation to total serum ILA. (1967) (50)
Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations. (1987) (47)
Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I. (1996) (47)
Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. (1982) (47)
Effect of Glycemic Control on Serum Insulin-like Growth Factors in Diabetes Mellitus (1984) (47)
[Hereditary fructose intolerance, a congenital metabolic disorder unknown until now]. (1957) (44)
Insulin-like growth factor in pregnancy: studies in a growth hormone-deficient dwarf. (1982) (44)
Effects of insulin on glucose metabolism and glucose transport in fat cells of hormone-treated hypophysectomized rats: evidence that growth hormone restricts glucose transport. (1979) (42)
Effects of insulin-like growth factors on chick embryo hepatocytes. (1985) (41)
Pathophysiological and clinical aspects of the insulin-like growth factors. (1986) (40)
Insulin-like growth factors (IGFs) in pygmies and subjects with the pygmy trait: characterization of the metabolic actions of IGF I and IGF II in man. (1982) (40)
Effects of Insulin and of NSILA‐S on the Perfused Rat Heart: Glucose Uptake, Lactate Production and Efflux of 3–0‐Methyl Glucose (1975) (39)
Nonsuppressible insulin-like activity of human serum. (1967) (37)
Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs. (1976) (37)
Insulin inhibition of spontaneous adipose tissue lipolysis and effects upon fructose and glucose metabolism. (1965) (36)
Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. (1997) (35)
Insulin-like growth factors (IGF) I and II and IGF binding proteins (IGFBPs) in human colostrum/transitory milk during the first week postpartum: comparison with neonatal and maternal serum. (1993) (32)
Mechanism of the glucosuria produced by the administration of steroids with glucocorticoid activity. (1958) (31)
Pathophysiology of edema. (1956) (31)
Prostaglandin E2 stimulates synthesis of insulin‐like growth factor binding protein‐3 in rat bone cells in vitro (1992) (30)
Binding of insulin and nonsuppressible insulin-like activity to isolated perfused rat heart muscle. Evidence for two separate binding sites. (1976) (30)
Binding of nonsuppressible insulin‐like activity (NSILA) to isolated fat cells: Evidence for two separate membrane acceptor sites (1976) (30)
Fructose metabolism in adipose tissue. (2009) (30)
The role of insulin-like growth factor I in growth of diabetic rats. (1989) (29)
Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart. (1977) (27)
Increased sensitivity of rat adipose tissue to the lipolytic action of epinephrine during fasting and its reversal during re‐feeding (1977) (27)
Effects of hormones on cyclic AMP release from rat adipose tissue in vitro (1974) (27)
Insulin-like growth factor I and II in 14 animal species and man as determined by three radioligand assays and two bioassays. (1987) (27)
Comparative Study of the Metabolism of U‐14C‐Fructose, U‐14C‐Sorbitol and U‐14C‐Xylitol in the Normal and in the Streptozotocin‐Diabetic Rat* (1971) (25)
Increased sensitivity to lipolytic hormones of adenylate cyclase in fat cells of diabetic rats. (1980) (24)
Hereditary fructose intolerance. Dental status of eight patients. (1967) (24)
Comparison of renal and hepatic effects of fasting, cortisone administration and glucose infusion in normal and adrenalectomized rats. (1958) (23)
Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity. (1995) (20)
Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat. (1998) (20)
Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures. (1996) (20)
Effects of 5-methylpyrazole-3-carboxylic acid on adipose tissue. I. Inhibition of lipolysis, effects on glucose, fructose, and glycogen metabolism in vitro and comparison with insulin. (1967) (20)
Expression, effects, and fate of IGFBP-5 are different in normal and malignant osteoblastic cells. (1995) (18)
3Disorders of fructose metabolism (1976) (18)
Glucose transport in adipocytes and its control by growth hormone in vivo. (1982) (18)
Metabolic Effects of IGFs (1999) (17)
Non-suppressible insulin-like activity of human serum. VI. Difference between the action of insulin and that of precipitated non-suppressible insulin-like activity on glycogen synthesis of rat adipose tissue and muscle. (1971) (17)
In vivo effects of the insulin-like growth factors (IGFs) in the hypophysectomized rat: comparison with human growth hormone and the possible role of the specific IGF carrier proteins. (1985) (17)
Small stature and insulin-like growth factors: prolonged treatment of mini-poodles with recombinant human insulin-like growth factor I. (1989) (17)
In vivo control of insulin-sensitive phosphodiesterase in rat adipocytes by growth hormone and its parallelism to glucose transport. (1981) (16)
The determination of inulin in blood and urine using glucose oxidase for the removal of interfering glucose. (1957) (15)
Regulation of rat adipocyte glucose transport by growth hormone: no mediation by insulin-like growth factors. (1983) (14)
Insulin-Like Growth Factor I Actions on Somatic Growth (2011) (14)
Insulin, IGF-I and growth in diabetic rats (1987) (14)
Mechanism of the antilipolytic action of NSILA-S: inhibition of adenylate cyclase activity in lipocyte ghosts. (1973) (13)
[INSULIN ACTIVITY IN THE HUMAN SERUM SUPPRESSIBLE AND NON-SUPPRESSIBLE WITH ANTI-INSULIN SERUM]. (1964) (13)
Effects of 5-methylpyrazole-3-carboxylic acid on adipose tissue. II. Antilipolytic and hypoglycemic effects in vivo. (1967) (13)
Effects of insulin and NSILA on adipocytes of normal and diabetic rats: Receptor binding, glucose transport and glucose metabolism (1977) (12)
The pathogenesis of tumour hypoglycaemia: Blocks of hepatic glucose release and of adipose tissue lipolysis (1967) (12)
Effects of Insulin‐Like Growth Factor I in Man (1990) (12)
Hereditary fructose intolerance. (1959) (11)
NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart (1978) (10)
BIOLOGICAL EFFECTS AND RECEPTOR BINDING OF NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY (NSILA) (1978) (10)
Insulin response to fructose and galactose. (1963) (10)
Inhibition of insulin degradation by insulin-like growth factors I and II in human hepatoma (HepG2) cells. (1989) (10)
Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats (2004) (10)
[ON THE PATHOGENESIS OF TUMOR-INDUCED HYPOGLYCEMIA WITHOUT HYPERINSULINISM]. (1963) (10)
Spontaneous postoperative normalization of growth hormone levels in two patients with acromegaly not cured by transsphenoidal surgery. (1988) (9)
Transport and metabolism of fructose in fat cells of normal and hypophysectomized rats. (1979) (9)
Congenital familial thyroid aplasia. (1981) (9)
Resistance to subcutaneous and intramuscular insulin associated with deficiency of insulin-like growth factor (IGF) 2. (1983) (8)
IGFs: function and clinical importance 1 Editorial introduction (1993) (8)
1 alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts. (1996) (8)
[Hereditary fructose intolerance]. (1959) (7)
The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation. (1977) (7)
[A patient with 46 XX/46 XY chimerism without hermaphroditism. The problem of prepuberal diagnosis of the Klinefelter's syndrome]. (1983) (7)
Hyperglycemic Effect without Anabolic Effect of Beef Growth Hormone in Man (1957) (6)
Differential mood response to natural and synthetic corticosteroids after bilateral adrenalectomy: a case report. (1994) (6)
[Advances in the diagnosis of diabetic acidosis and their consequences for therapy]. (1960) (6)
Nonsuppressible insulin-like activity: biological activity and receptor binding. (1975) (6)
[The effect of glucagons on adipose tissue]. (1960) (5)
Is increased basal lipolysis in adipose tissue of fasted-refed rats related to cyclic-AMP-dependent mechanisms? (1981) (5)
[Persistent disorders of ACTH secretion following surgery of an adrenal cortex adenoma in 3 cases of Cushing's syndrome]. (1967) (5)
Recombinant human insulin-like growth factor I: effects in normal subjects and implications for use in patients. (1991) (5)
[Malignant hyperthermia: attempt at an early diagnosis by means of determination of creatine phosphokinase (CPK) and its isoenzymes]. (1976) (4)
The Site of Action of the Arylsulfonylureas in Man (1957) (4)
Eleven cases of hereditary fructose intolerance in one Swiss family with a pair of monozygotic and of dizygotic twins. (1981) (4)
[The therapy of diabetic coma: quantitative value of insulin loss on the infusion instruments]. (1975) (4)
Protein kinases from rat skeletal muscle: Evidence for six different fractions of the enzyme (1972) (4)
Recent investigation of the nature of nonsuppressible, acid ethanol soluble insulin-like activity (NSILA-S). (1972) (4)
In-frame exon 2 deletion in insulin receptor RNA in a family with extreme insulin resistance in association with defective insulin binding: a case report. (1996) (4)
[The current status of the functional diagnosis of adrenal cortex]. (1959) (3)
Non-suppressible insulin-like activity during acute metabolic and endocrine changes in dogs. (1977) (3)
Letters to the EditorSMALL DOSES OF INTRAMUSCULAR INSULIN IN THE TREATMENT OF DIABETIC " COMA " (1973) (3)
[Acromegaly and insulin-like growth factors]. (1986) (3)
Therapeutic agents produced by genetic engineering: Quo vadis? The example of growth hormone and its releasing factor. Satellite symposium. Toulouse-Labège, May 29-30, 1985. (1986) (3)
Increased sensitivity of diabetic rat adipose tissue towards the lipolytic action of epinephrine (1975) (2)
[Diagnostic ues of a new adrenostatic drug]. (1959) (2)
Comparison of Pancreatic Human and Biosynthetic Human Insulin with Respect to Their Action on Adipocytes and Chick Embryo Fibroblasts (1981) (2)
Biological effects of the insulin-like growth factors in vitro: relevance to their actions in vivo. (1981) (2)
FROM NSILA TO IGF: A LOOK BACK ON THE MAJOR ADVANCES AND BREAKTHROUGHS (1983) (2)
The effect of different extraction procedures on two different molecular weight species of serum NSILA and on the carrier protein of small molecular weight NSILA (NSILA-S). (1979) (2)
INSULIN-LIKE GROWTH FACTOR (IGF) LEVELS MEASURED BY RADIOIMMUNOASSAY (RIA) AND RADIORECEPTORASSAY (RRA) IN VARIOUS FORMS OF TUMOR HYPOGLYCEMIA (1983) (2)
[Serum insulin activity not inhibitable by insulin antibodies]. (1966) (2)
[The influence of insulin and oral antidiabetics on the glucose uptake and gas exchange of isolated fatty tissue]. (1959) (2)
[New studies on the nature of the non-suppressible insulin-like activity (NSILA) of human serum]. (1970) (2)
LONG-TERM IN VIVO EFFECTS OF INSULIN-LIKE GROWTH FACTORS (IGF) I AND II ON GROWTH INDICES: DIRECT EVIDENCE IN FAVOR OF THE SOMATOMEDIN HYPOTHESIS (1983) (2)
Second Annual Meeting of the European Association for the Study of Diabetes abstracts (1966) (1)
[Deficient dental caries attack in persons with hereditary fructose intolerance]. (1967) (1)
[Clinical trial of a vasopressin analog, DDAVP, in 4 patients with diabetes insipidus]. (1974) (1)
IGFs: function and clinical importance. (1993) (1)
Fructose metabolism in adipose tissue from normal and diabetic rats1 (2011) (1)
Nutrition and diabetes mellitus = Nutrizione e diabete mellito : VI Capri Conference 29-30 III 1972 (1972) (1)
[Feminizing testicular Leydig cell tumor. Case contribution to the differential diagnosis of gynecomastia]. (1981) (1)
Clinical and metabolic aspects of fructose. Concluding remarks. (1972) (1)
1 2 5I-IGF BINDING PATTERNS IN SERUM AND GLUCOSE TRANSPORT IN FAT CELLS FROM HYPOX RATS AFTER LONG-TERM TREATMENT WITH IGF I, IGF II OR GROWTH HORMONE (GH): EVIDENCE FOR EFFECTS OF GH NOT MEDIATED BY IGF (1983) (1)
IGFs/somatomedins: significance for growth. (1985) (1)
[Metabolism of fructose, essential fructosuria and hereditary fructose intolerance]. (1965) (1)
Non Suppressible Insulin Like Activity (2008) (1)
[Insulin-like growth factors (IGF I and IGF II) and diabetes]. (1990) (1)
[The degradation of insulin by the isolated rat liver perfused with rat serum and leucine]. (1966) (0)
Disorders of fructose metabolism (1969) (0)
[Parenteral feeding: glucose or glucose substitutes?]. (1978) (0)
[Therapy of diabetic coma]. (1981) (0)
[Scientific raisins from 125 years SMW (Swiss Medical Weekly). Diagnostic use of a new adrenostatic agents. 1959]. (1995) (0)
[INSULIN ACTIVITY IN HUMAN BLOOD, INHIBITABLE AND NOT INHIBITABLE WITH ANTI-INSULIN BLOOD]. (1964) (0)
[Prevention of diabetic angiopathy?]. (1971) (0)
[Diabeti coma from the present viewpoint]. (1966) (0)
[Infusion solutions with fructose and sorbitol]. (1983) (0)
[Incidence and clinical manifestation of ACTH-producing pituitary adenoma after bilateral adrenalectomy for Cushing's syndrome (Nelson syndrome)]. (1981) (0)
[TSH-producing hypophysis adenoma and secondary hyperthyroidism. Case presentation and literature review]. (1989) (0)
[No dental caries in individuals with hereditary fructose intolerance]. (1967) (0)
Bone, Calcium, and Phosphate Metabolism (1979) (0)
[Experimental medicine and diabetes]. (1967) (0)
Estimation of glucose in blood and urine with glucose oxidase. (1955) (0)
[Cushing's syndrome. Case report of 43 patients with Cushing syndrome at the medical university clinic in Zurich in the years 1958-1969]. (1971) (0)
IN VIVO METABOLIC ACTIONS OF IGF I (1993) (0)
[FAULTY REGULATION OF THE THIRST CENTER. ON THE DIFFERENTIAL DIAGNOSIS BETWEEN ORGANIC POLYDIPSIA AND TRUE DIABETES INSIPIDUS]. (1964) (0)
[Growth factors with identical insulino-situations : IGF I and II, NSILA and somatomedins (author's transl)]. (1980) (0)
[Insulin activity in the blood of the V. hepatica and V. portae after intravenous carbutamide in man]. (1959) (0)
[Not Available]. (1959) (0)
[IGFs/somatomedins: physiological and physiopathological significance]. (1985) (0)
[Turnover and utilization of glucose and glucose substitutes in human and animals]. (1975) (0)
III. DIFFERENTIATION OF TWO DISTINCT MOLECULES WITH NONSUPPRESSIBLE ILA (1968) (0)
[Treatment of diabetes mellitus with oral antidiabetics]. (1976) (0)
Letter: Small doses of intramuscular insulin in the treatment of diabetic "coma". (1973) (0)
[Report on four years' practical experience with AM 49 in the treatment of bronchial asthma]. (1951) (0)
[On aldolases. 4. Enzyme activity in the liver in hereditary fructose intolerance]. (1963) (0)
[Prolactin producing hypophyseal adenoma: diagnosis and therapeutic possibilities]. (1985) (0)
[Diabetic coma]. (1965) (0)
[PATHOGENESIS AND DIFFERENTIAL DIAGNOSIS OF HYPOGLYCEMIA]. (1963) (0)
[Tubular kidney function in various forms of renal diabetes mellitus]. (1957) (0)
[Pathogenesis and differential diagnosis of hypoglycemias]. (1962) (0)
Abstracts of Selected Free Communications (1986) (0)

This paper list is powered by the following services:

E. Rudolph Froesch's Academic­Influence.com Rankings

E. Rudolph Froesch's Degrees

Why Is E. Rudolph Froesch Influential?

E. Rudolph Froesch's Published Works

Published Works

E. Rudolph Froesch's AcademicInfluence.com Rankings